Ritu Roy
Impact in
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 4
- Co-authors
- Boris C. Bastian (5 shared papers)Klaus J. Busam (2 shared papers)Michelle B. Crosby (1 shared paper)Joan M. O’Brien (1 shared paper)Werner Wackernagel (1 shared paper)Mert Sozen (1 shared paper)Igor Dolgalev (1 shared paper)Nancy Bouvier (1 shared paper)
- Journals
- Cancer Research (4 papers)Blood (3 papers)Epigenetics (3 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesSouth KoreaAustralia
In The Last Decade
Ritu Roy
64 papers receiving 2.9k citations
Ritu Roy's Hit Papers
Peers
Comparison fields: 5 of 111
- Ophthalmology 673
- Cancer Research 518
- Oncology 903
- Immunology 341
- Molecular Biology 1.1k
Countries citing papers authored by Ritu Roy
This map shows the geographic impact of Ritu Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Roy more than expected).
Fields of papers citing papers by Ritu Roy
This network shows the impact of papers produced by Ritu Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Roy. The network helps show where Ritu Roy may publish in the future.
Co-authors
The 25 scholars most cited alongside Ritu Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in GNA11 in Uveal Melanoma Hit paper breakdown → | 2010 | 1058 |
| 2 | 2010 | 114 | |
| 3 | 2018 | 113 | |
| 4 | 2009 | 98 | |
| 5 | 2008 | 89 | |
| 6 | 2011 | 88 | |
| 7 | 2012 | 78 | |
| 8 | 2009 | 76 | |
| 9 | 2018 | 68 | |
| 10 | 2012 | 62 | |
| 11 | 2017 | 55 | |
| 12 | 2011 | 55 | |
| 13 | 2013 | 53 | |
| 14 | 2009 | 52 | |
| 15 | 2011 | 48 | |
| 16 | 2019 | 47 | |
| 17 | 2019 | 44 | |
| 18 | 2013 | 42 | |
| 19 | 2014 | 38 | |
| 20 | 2019 | 38 |
About Ritu Roy
Ritu Roy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Cancer Research, having authored 65 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Genomic variations and chromosomal abnormalities (6 papers), Cancer Cells and Metastasis (5 papers), Glioma Diagnosis and Treatment (4 papers), RNA modifications and cancer (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Ophthalmology (673 citations), Cancer Research (518 citations), Oncology (903 citations), Immunology (341 citations) and Molecular Biology (1.1k citations). Ritu Roy has collaborated with scholars based in United States, South Korea and Australia. Frequent co-authors include Boris C. Bastian, Klaus J. Busam, Michelle B. Crosby, Joan M. O’Brien, Werner Wackernagel, Mert Sozen, Igor Dolgalev, Nancy Bouvier, Gary Green and María C. Garrido. Their work appears in journals such as Cancer Research, Blood, Epigenetics, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.